Volta

Epidemic Mitigation and Marginal Mortality Gains Using Self-Testing as a Diagnostic Intervention for Epidemic-Prone Diseases in Africa

Unknown authors · 2026
hash_id: c7ce9d4bafb689307e5fa0bab59b3750f40e411f9840030908ff3f689efe4d36 · DOI: 10.3390/diagnostics16132092

Background/Objectives: African Union (AU) guidance identifies decentralized diagnostics as central to epidemic preparedness. However, the epidemiological role of self-testing across epidemic-prone diseases remains underexplored. Drivers for the potential impact of self-testing were examined conceptually using a transmission model. Methods: A deterministic SEIR model compared standard-of-care testing with additional self-testing. Global sensitivity analysis using Latin Hypercube sampling and partial rank correlation coefficients (PRCCs) examined parameters influencing reductions in peak disease prevalence (mitigation). Dynamics were illustrated using AU pathogen archetypes (Ebola, Influenza A, Cholera, Coronavirus, and Mpox), estimating the number needed to self-test (NNST) to avert one death. Results: Epidemic mitigation was minimal (median 1.9%; IQR: 0.4–5.8%); this correlated with isolation adherence (PRCC = 0.784), self-testing intensity (PRCC = 0.617), lower R0 …

Reference & gravity metrics

Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP

Secondary-market trade history

No secondary-market trades recorded for this Volta yet.

References (0)

No outbound references recorded.

Cited by (1)

Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: an up… secondary